Apatinib as the First-Line Therapy in Elderly Locally Advanced or Metastatic Gastric Cancer
NCT03219593
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Gastric Cancer
Apatinib
Biomarker
Interventions
DRUG:
Apatinib mesylate tablets
Sponsor
The First Affiliated Hospital of Bengbu Medical University